Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TELA Bio (TELA) EBT Margin (2018 - 2025)

TELA Bio has reported EBT Margin over the past 8 years, most recently at 145.0% for Q4 2025.

  • Quarterly results put EBT Margin at 145.0% for Q4 2025, down 2072.0% from a year ago — trailing twelve months through Dec 2025 was 0.69% (down 19.0% YoY), and the annual figure for FY2025 was 0.69%, down 19.0%.
  • EBT Margin for Q4 2025 was 145.0% at TELA Bio, up from 41.58% in the prior quarter.
  • Over the last five years, EBT Margin for TELA hit a ceiling of 165.72% in Q4 2024 and a floor of 138.81% in Q1 2021.
  • Median EBT Margin over the past 5 years was 80.3% (2023), compared with a mean of 61.44%.
  • Biggest five-year swings in EBT Margin: surged 24587bps in 2024 and later tumbled -2644bps in 2025.
  • TELA Bio's EBT Margin stood at 102.41% in 2021, then grew by 11bps to 91.32% in 2022, then grew by 12bps to 80.14% in 2023, then skyrocketed by 307bps to 165.72% in 2024, then dropped by -13bps to 145.0% in 2025.
  • The last three reported values for EBT Margin were 145.0% (Q4 2025), 41.58% (Q3 2025), and 48.97% (Q2 2025) per Business Quant data.